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IDENTITY OF Leu-19 (CD56) LEUKOCYTE
DIFFERENTIATION ANTIGEN AND NEURAL CELL
ADHESION MOLECULE
BY LEWIS L. LANIER, ROBERTO TESTI, JANE BINDL,
AND JOSEPH H. PHILLIPS
From Becton Dickinson Monoclonal Center, Inc., Mountain View, California 94043
Cell surface receptors that are involved in cellular adhesion have been identified
on several cell types in hematopoietic, muscle, and neural tissues (1, 2) . This group
of molecules includes fibronectin receptors, vitronectin receptors, platelet adhesion
molecules, the leukocyte-associated CDII/CD18 andVLA glycoprotein complexes,
and the neural cell adhesion molecule (N-CAM) glycoprotein (1, 2) . These struc-
tures have been implicated in embryonic development, cell migration, and cellular
adhesion, and often are highly conserved during evolution. The N-CAM antigen
initially was identified in chicken neural tissue (1, 2) . Chicken N-CAM is encoded
by a single gene ; however, numerous isoforms can be generated by differential RNA
splicing and post-translational modifications, including the addition ofN-linked car-
bohydrates and polysialic acid (2). Homologous N-CAM glycoproteins have been
identified in humanneural tissues (3). Recently, N-CAMcDNA isolated from human
muscle tissue have been cloned and sequenced (4). Several isoforms of N-CAMexist,
including modifications that permit attachment to the cell membrane by either a
transmembrane polypeptide or phosphatidylinositol glycan (5).
The CD56 differentiation antigen, recognized by mAb anti-Leu-19 and NKH-1,
is a x+175-185-kD glycoprotein that is expressed on essentially all human NK cells
andon a subset ofT lymphocytes and IL-2-activated thymocytes that mediate MHC-
unrestricted cytotoxicity (6, 7) . However, expression of Leu-19/NKH1 is not restricted
to cytotoxic cells, since this antigen is present on certain CD4+ Th cell clones, some
myeloid leukemias, and the KGla immature hematopoietic leukemia cell line (8).
Herein, we report that Leu-19 also is expressed on neural tissues and is identical
to N-CAM.
Materials and Methods
Cells .
	
KGla.5 is a cloned subline of the KGla immature hematopoietic cell line that was
selected for high levels of Leu-19 antigen on the cell surface (6) . The SK-N-SH neuroblas-
toma cell line was generously provided by Ms. Roxanne Duan and Dr. Wolfgang Sadee (Univer-
sity of California, San Francisco) . NK cells and Leu-19' T lymphocytes were isolated from
peripheral blood and cultured in growth medium containing rIL-2, as described (6, 8) .
Antibodies. Anti-Leu-19 mAb was produced as described (6) . Rabbit antiserum against
humanN-CAM was generously provided by Dr. Frank Walsh (Institute ofNeurology, London) .
Immunoprecipitation, Deglycosylation, and Electrophoresis . Radioiodination, immunoprecipi-
tation, and electrophoresis were performed as described (9) . Immunoprecipitates were treated
with 1 U/ml neuraminidase (from C. perfiingens ; Sigma Chemical Co ., St. Louis, MO) in
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Tris-maleate buffer (20mM Tris-maleate, 10 MM D-galactono-,y-lactone, 1 mM calcium ace-
tate, 0.5% NP-40, 0.02 mg/ml trypsin inhibitor, 1 mM PMSF, pH 6.0) for 4 h at 37'C . Diges-
tion with Endo F was performed as recommended by New England Nuclear (Boston, MA).
Peptide mapping was performed as described by Cleveland et al . (10), using protease type
XVII from Staphylococcus aureus strain V8 (Sigma Chemical Co.) .
Results and Discussion
N-CAMis a membrane glycoprotein expressed on neural and muscle tissues that
is involved in homotypic adhesive interactions . Recently, we have observed that Leu-
19 (CD56) is present on human neural tissues and neural-derived cell lines. In spinal
cord, Leu-19 was strongly expressed throughout the gray and white matter. Cell
surface staining was particularly prominent on the radiating glial septae of the white
matter. In brain, Leu-19 was widely expressed throughout the molecular and granular
layers of the cerebellum, as well as the cortex . These findings were consistent with
the distribution of N-CAM on neural tissues and suggested that Leu-19 maybe similar
to N-CAM.
The presence of Leu-19 on neural tissues prompted us to examine whether it is
related to N-CAM . KGla.5, an immature hematopoietic cell line, and SK-N-SH,
a neuroblastoma cell line, were labeled with "'I and detergent solubilized. Antigens
were immunoprecipitated using anti-Leu-19 mAb and rabbit anti-N-CAM serum.
Samples were treated with neuraminidase and analyzed by SDS-PAGE . Anti-Leu-
19 and anti-N-CAM immunoprecipitated a predominant band of -145 kD from
both the hematopoietic and neuroblastoma cells (Fig. 1 A) . Mobility of Leu-19 was
essentially identical when analyzed using both reducing (Fig. 1) and nonreducing
conditions (not shown) . Sequential immunoprecipitation confirmed that anti-Leu-
19 and anti-N-CAM reacted with the same molecule (Fig. 1 B) . Moreover, peptide
mapping usingS aurew V8 protease indicated that the Leu-19 glycoproteins expressed
on the hematopoietic and neuroblastoma cells were indistinguishable (Fig. 2) . These
results clearly demonstrate that anti-Leu-19 mAb reacts with the N-CAM molecule,
and that the structure expressed on hematopoietic cells is similar to the form present
on a neural cell line . Northern blot analysis revealed N-CAM transcripts in both
KGla.5 and NK cell lines (S. Cwirla and L. Lanier, unpublished observation) .
Although N-CAM is encoded by a single gene, several isoforms can be generated
by alternative splicing and differential polyadenylation (3, 5) . Polypeptides of 180,
140, and 120 kD have been isolated from neural tissue, and 155-, 145-, and 125-kD
proteins are present in muscle tissue (1, 2) . The smaller forms (120 and 125 kD)
are anchored to the cell membrane via a phosphatidylinositol glycan linkage, whereas
the larger forms possess atransmembrane peptide segment (5). Additional diversity
in N-CAM structure can be conferred by glycosylation, phosphorylation, sulpha-
tion, and sialyation (1, 2) .
In hematopoietic tissues, Leu-19 is expressed on several cell types, including NK
cells, T lymphocytes, and some myeloid leukemias (6-8). Since N-CAM can be ex-
pressed as several structural isoforms, further studies were conducted to compare
the biochemical properties of Leu-19 expressed on hematopoietic cell types. Leu-19
immunoprecipitates prepared from '211-labeled lysates of NK cells, Leu 19+ T cells,
and KGla.5 were treated with Endo F to remove N-linked carbohydrates and ana-
lyzed by SDS-PAGE . Deglycosylated Leu-19 expressed by NK cells and Leu-19+ T
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FIGURE 1 . Immunoprecipitation ofLeu-19 and N-CAM. (A) SK-N-SH neuroblastomaand KGla.5
cells were labeled with 12 '1 and detergent solubilized . Lysates were immunoprecipitated with
control Ig, anti-N-CAM, and anti-Leu-19. (B) 1211 KGla.5 lysates were substantially depleted
of Leu-19 or CD45 by immunoprecipitation with anti-Leu-19 and anti-CD45, respectively. After
depletion, lysates were immunoprecipitated with anti-Leu-19, anti-CD45, and rabbit anti-N-CAM .
Immunoprecipitates were treated with neuraminidase and analyzed by SDS-PAGE (reducing
conditions) using 10% acrylamide gels . As reported previously (6), Leu-19 immunoprecipitates
not treated with neuraminidase migrated as diffuse bands of -175-185 kD (not shown) .
lymphocytes is a 137-kD protein, similar to the polypeptide expressed on KGla.5
(Fig. 3) . Note that before deglycosylation, the mobility ofLeu-19 isolated from normal
T and NK cells was similar to the mobility of Leu-19 on KG1a.5, indicating that
the extent of sialyation is similar in these cell types.
Further biochemical analysis of Leu-19 expressed on hematopoietic cells indicated
that the glycoprotein was resistant to cleavage by EndoH and 0-glycanase, enzymes
that remove high mannose and 0-linked carbohydrates, respectively (not shown) .
Therefore, it appears that the carbohydrates present on Leu-19 on hematopoietic
cells are exclusively complex N-linked oligosaccharides with abundant sialyation .
Leu-19 on hematopoietic cells was resistant to removal by phosphatidylinositol phos-
pholipase C (PIPLC) (not shown) . Given the size of the polypeptide (140 kD) and
the inability to cleave Leu-19 using PIPLC, the molecule is likely anchored to the
membrane via a transmembrane peptide.
An unusual structural feature of N-CAM is the abundance of sialic acid on this
molecule (3). The extent of sialyation changes during embryonic development and
can influence N-CAMbinding function (11) . We have shown that the epitope recog-
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FIGURE 2. Peptide mapping ofLeu-19. Leu-
19 bands were cut from the SK-N-SH neuro-
blastoma (Nb) and KGla.5 (K) lanes shown
in Fig. 1, digested for 1 h with 0, 5, and 25
jig of S aurtus V8 protease, and analyzed by
SDS-PAGE (reducing conditions) using a 15 %
acrylamide gel .
nized by anti-Leu-19 mAb is not dependent on sialic acid, since treatment of viable
cells with neuraminidase did not diminish the binding of anti-Leu-19 as determined
by flow cytometry (not shown) . In fact, neuraminidase treatment increased binding
of anti-Leu-19, indicating that Leu-19 epitopes are partially masked by sialic acid .
We have observed that the amount of Leu-19 increases on NK cells after activation
with IL-2 (unpublished observation), and that subsets of NK cells can be identified
FIGURE 3. Immunoprecipitation of Leu-19 from
NK cells, T cells, and KGla.5 . KGla .5 cells,
CD3-, Leu-19' NK cells, and CD3', Leu-19' T
cells were labeled with 1211 and detergent solu-
bilized . Lysates were immunoprecipitated with
anti-Leu-19 . Leu-19 glycoproteins were deglyco-
sylated with Endo Fand analyzed by SDS-PAGE
(reducing conditions) using 7 % acrylamide gels .
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based on relative density of Leu-19 expression (6) . It will be interesting to determine
whether this increase in Leu-19 is a result of de novo protein synthesis or alteration
in sialyation . As in neural cells, sialyation may affect the function of Leu-19 on leu-
kocytes .
In normal lymphoid tissues, Leu-19 is expressed predominantly on NK cells and
a subset of T lymphocytes that mediate MHC-unrestricted cytotoxicity (6-8) . Al-
though this preferential distribution suggests that Leu-19 may be important in cyto-
toxicity, the function ofLeu-19 on these cells has not been determined. Anti-Leu-19
mAb does not inhibit cytotoxic activity of NK or T cells against several tumor cell
targets and does not affect IL-2-induced cellular proliferation (6-8) . However, nega-
tive results from antibody blocking studies are inconclusive . Given the role of N-
CAM in neural cell adhesion, it is conceivable that Leu-19 also may be involved
in lymphocyte adhesion . Further studies will be necessary to examine this possibility.
Summary
Neural cell adhesion molecule (N-CAM) is a membrane glycoprotein expressed
on neural and muscle tissues that is involved in homotypic adhesive interactions .
We have demonstrated that N-CAM also is expressed on hematopoietic cells, and
is recognized by the anti-Leu-19 mAb. Leu-19 is preferentially expressed on NK
cells and T lymphocytes that mediate MHC-unrestricted cytotoxicity, but is also
present on some myeloid leukemia cell lines . On NK cells, T cells, the KGla.5 he-
matopoietic cell line, and a neuroblastoma cell line, Leu-19 is a ti 140-kD polypep-
tide with N-linked carbohydrates and abundant sialic acid residues . Sequential im-
munoprecipitation and peptide mapping demonstrated that the Leu-19 and N-CAM
molecules expressed on leukocyte and neuroblastoma cell lines are similar struc-
tures . These findings suggest that the Leu-19 antigen on leukocytes may be involved
in cell adhesion, analogous to the function of N-CAM on neural cells .
We thank Dr. Frank Walsh for providing antiserum, Dr. Martin Low for providing PIPLC,
Ms. Roxanne Duan and Dr. Wolfgang Sadee for providing neuroblastoma cell lines, Drs .
Heidi Phillips andJim Allison for helpful discussion, and Ms . Nga T Bui, and Mr. Andrew
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